CTRI/2023/07/055235尚未招募2 期
Efficacy and safety of Asaroon in primary dysmenorrhea in comparison with mefenamic acid: A randomized double blind standard controlled trial - Nil
uqman Unani Medical College Hospital and Research Centre0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Married and unmarried patients between 15 to 35 years of ages having regular menstrual cycles
- •Patient diagnosed with primary dysmenorrhea
- •Patients with Visual Analog Scale less than or equal to 4cm for at least three menstrual cycles before this study
排除标准
- •Pelvic disease such as fibroid adenomyosis PID endometrial polyp ovarian tumour
- •Irregular menstrual cycles
- •Pregnancy and lactation
- •Systemic illness
- •Oral contraceptives and those Wearing IUCD devices
- •Participants with congenital anomalies of uterus
研究者
相似试验
尚未招募
不适用
Evaluation of the Efficacy and Safety of Drospirenone in the Treatment of AdenomyosisAdenomyosisNCT06174792University of Palermo40
招募中
3 期
Comparison the use of dyrogesterone and steroid in IVF Cycles.Female infertility.Female infertilityIRCT20181031041519N2Tehran University of Medical Sciences200
已完成
1 期
The Safety of Edaravone for patients with Amyotrophic Lateral Sclerosis: Single centered open label trialamyotrophic lateral sclerosisJPRN-UMIN000016352Ehime University Hospital10
尚未招募
2 期
Herbal treatment for dysmenorrheaCTRI/2023/04/052139ational institute of unani medicine
尚未招募
不适用
The sustained effects of Osteopathic Treatment on Primary DysmennorhoeaACTRN12610000265077Dr. Brian Nicholls20